Roundup: Thai researchers develop AI for assessing stroke risk and more briefs
Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
Go to Source
2023-03-03 09:55
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
